{"gene":"KCNV2","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2006,"finding":"KCNV2 is expressed in human rod and cone photoreceptors (demonstrated by in situ hybridization), and loss-of-function mutations cause cone dystrophy with supernormal rod ERG, suggesting KCNV2 encodes a subunit that perturbs or abrogates IKX, the potassium current within vertebrate photoreceptor inner segments that sets their resting potential and voltage response.","method":"In situ hybridization; homozygosity mapping; Sanger sequencing of disease-linked mutations","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational discovery paper with >100 citations, direct localization experiment plus genetic linkage to channel function","pmids":["16909397"],"is_preprint":false},{"year":2007,"finding":"Kv8.2 (KCNV2) cannot form homotetrameric channels on its own but co-assembles with Kv2.1 to form functional heteromeric channels. In Xenopus oocytes, Kv8.2 shifts Kv2.1 steady-state activation to more negative potentials, generating a window current in the −40 to −10 mV range, and produces transient hyperpolarizing overshoots resembling photoreceptor responses to light. The disease-causing mutation G476D abolishes functional heteromer formation.","method":"Heterologous expression in Xenopus oocytes; two-electrode voltage clamp; current-clamp experiments; site-directed mutagenesis","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted heteromeric channel in oocytes with mutagenesis validation, >60 citations","pmids":["17652418"],"is_preprint":false},{"year":2011,"finding":"KCNV2 (Kv8.2) contributes to epilepsy susceptibility by modulating Kv2.1/Kv8.2 heterotetrameric potassium channel function; nonsynonymous human KCNV2 variants identified in epilepsy patients alter Kv2.1/Kv8.2 channel function, and Kcnv2 transgene overexpression exacerbates seizure severity in a mouse model (Scn2a Q54).","method":"Transgenic mouse in vivo epilepsy model; electrophysiology of heteromeric channels; identification of nonsynonymous variants with functional assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo exacerbation by transgene plus functional channel assay, >70 citations","pmids":["21402906"],"is_preprint":false},{"year":2011,"finding":"N-terminal missense mutations in Kv8.2 (KCNV2) dramatically reduce or abolish interaction with Kv2.1, as shown by yeast two-hybrid assay, indicating that failure of heteromeric Kv channel assembly is one underlying pathomechanism of cone dystrophy with supernormal rod response.","method":"Yeast two-hybrid interaction assay with disease-associated KCNV2 N-terminal missense mutations","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 — single method (yeast two-hybrid), but consistent with oocyte functional data from other labs","pmids":["21882291"],"is_preprint":false},{"year":2012,"finding":"Two distinct molecular mechanisms underlie KCNV2-associated disease: pore-domain missense mutations (W467G, G478R) allow Kv2.1/Kv8.2 heteromer assembly but render channels non-conducting, whereas tetramerization-domain missense mutations prevent heteromer formation and result in homomeric Kv2.1 channels only.","method":"Heterologous expression of mutant channels; patch-clamp electrophysiology; site-directed mutagenesis in tetramerization and pore domains","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional reconstitution with domain-specific mutagenesis distinguishing two mechanisms","pmids":["23115240"],"is_preprint":false},{"year":2012,"finding":"Transcription of Kcnv2 (and Kv2.1) in the retina follows a circadian rhythm driven by the endogenous retinal clock, with peak mRNA and Kv8.2 protein levels at night; this rhythm persists under constant darkness, indicating clock-controlled transcriptional regulation of potassium channel subunit expression in photoreceptors.","method":"Quantitative PCR of whole retina and microdissected photoreceptors across time; Western blot; constant-darkness experiments","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (qPCR + Western blot + constant darkness), single lab","pmids":["22969075"],"is_preprint":false},{"year":2014,"finding":"Retina-specific expression of Kcnv2 is controlled by the transcription factors Crx and Nrl; ChIP identified two Crx binding sites (CBS) and one Nrl binding site in the Kcnv2 promoter, with CBS2 shown to be essential by site-directed mutagenesis. In vivo electroporation showed that Kv8.2 protein localizes to the inner segment membranes of photoreceptors.","method":"Chromatin immunoprecipitation (ChIP); reporter electroporation of retinal explants; shRNA knockdown of Crx/Nrl; site-directed mutagenesis of promoter; qRT-PCR; in vivo electroporation for subcellular localization","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, mutagenesis, reporter assay, localization), single lab","pmids":["24664678"],"is_preprint":false},{"year":2019,"finding":"Kv8.2 (Kcnv2) knockout mice recapitulate key features of human CDSRR including a depressed a-wave and elevated b-wave with bright light stimulation; Kv2.1 KO mice show depressed a-wave but lack the elevated b-wave, indicating that homomeric Kv2.1 channels and heteromeric Kv2.1/Kv8.2 channels differentially contribute to ERG components. In all three KO genotypes (Kv8.2 KO, Kv2.1 KO, double KO), the c-wave is totally absent, linking the Kv2.1/Kv8.2 heteromeric channel to c-wave generation.","method":"Genetic knockout mouse models; electroretinography (ERG); OCT imaging; immunohistochemistry; TUNEL assay","journal":"eNeuro","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined ERG phenotype, reciprocal KO comparison clarifying channel composition requirement, multiple orthogonal readouts","pmids":["30820446"],"is_preprint":false},{"year":2021,"finding":"Loss of Kv8.2 (Kv8.2 KO mouse) causes early retinal pathology including significantly higher apoptotic cells, thinning of the outer nuclear layer, and increased activated microglia in the subretinal space, establishing that Kv8.2 is required for photoreceptor survival and normal retinal immune homeostasis.","method":"Kv8.2 and Kv2.1 knockout mouse models; TUNEL assay; OCT; immunohistochemistry for microglial markers; ERG","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with multiple orthogonal cellular phenotype readouts, single lab","pmids":["34063002"],"is_preprint":false},{"year":2021,"finding":"Disease-causing KCNV2 mutations cause either failure of Kv8.2 protein expression or failure of Kv8.2 to interact with Kv2.1, as demonstrated by immunoblotting and co-immunoprecipitation in vitro.","method":"Co-immunoprecipitation; immunoblotting; qRT-PCR in transfected cells","journal":"Molecular genetics & genomic medicine","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, single method (Co-IP/Western), but corroborates established mechanism from multiple prior studies","pmids":["34535971"],"is_preprint":false},{"year":2022,"finding":"Kv2.1 and Kv8.2 are direct interaction partners of the retinal Na/K-ATPase (ATP1A3 subunit) at the photoreceptor inner segment membrane, forming a macromolecular complex that also includes retinoschisin. Retinoschisin deficiency causes mislocalization of this complex and concurrent reduction of Kv2.1 and Kv8.2 protein levels without affecting Na/K-ATPase expression.","method":"Co-immunoprecipitation with porcine and murine retinal lysates; colocalization by immunofluorescence; patch-clamp analysis; retinoschisin-deficient mouse model","journal":"Cellular and molecular life sciences : CMLS","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP from native retinal tissue plus KO model showing functional complex mislocalization, multiple orthogonal methods","pmids":["35876901"],"is_preprint":false},{"year":2025,"finding":"KCNV2-deficient photoreceptors (in human retinal organoids) show upregulation of genes associated with apoptosis, oxidative stress, and hypoxia pathways; AAV-mediated KCNV2 replacement partially restores these transcriptional changes and rescues Kv8.2 protein expression and its interactions with potassium channel binding partners.","method":"KCNV2-deficient retinal organoids (iPSC-derived and CRISPR gene-edited); AAV transduction; single-cell RNA sequencing; immunofluorescence quantification of protein interactions","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — organoid loss-of-function with single-cell RNAseq and rescue by gene replacement, single lab","pmids":["41516321"],"is_preprint":false}],"current_model":"KCNV2 encodes Kv8.2, an electrically silent voltage-gated potassium channel α-subunit that cannot form homotetrameric channels alone but obligately co-assembles with Kv2.1 into heteromeric channels at photoreceptor inner segment membranes; within this heteromer, Kv8.2 shifts activation to more negative potentials and generates a window current (IKX) that sets the photoreceptor resting potential, while also forming part of a larger macromolecular complex with the retinal Na/K-ATPase and retinoschisin. Disease mutations cause either non-conducting heteromers (pore-domain mutations) or failure of heteromer assembly (tetramerization-domain mutations), leading to photoreceptor apoptosis and cone dystrophy with supernormal rod response. Kcnv2 transcription is clock-driven and regulated by the retinal transcription factors Crx and Nrl."},"narrative":{"teleology":[{"year":2006,"claim":"Identifying KCNV2 as the gene mutated in cone dystrophy with supernormal rod ERG established that an electrically silent Kv subunit expressed in photoreceptors is essential for normal visual function.","evidence":"Homozygosity mapping, Sanger sequencing of affected families, and in situ hybridization localizing KCNV2 mRNA to rod and cone photoreceptors","pmids":["16909397"],"confidence":"High","gaps":["Functional mechanism of Kv8.2 in photoreceptor physiology was unknown","Whether Kv8.2 formed channels alone or required a partner was untested"]},{"year":2007,"claim":"Reconstitution of Kv8.2/Kv2.1 heteromeric channels demonstrated that Kv8.2 cannot conduct alone but shifts Kv2.1 activation negatively, producing a window current resembling the photoreceptor IKX.","evidence":"Two-electrode voltage clamp of Kv8.2 ± Kv2.1 in Xenopus oocytes; current-clamp showing hyperpolarizing overshoots; G476D mutagenesis abolishing function","pmids":["17652418"],"confidence":"High","gaps":["In vivo confirmation in photoreceptors was lacking","Other potential heteromeric partners not excluded"]},{"year":2011,"claim":"Distinguishing pore-domain from tetramerization-domain mutations revealed two separable pathomechanisms — non-conducting assembled heteromers versus failure of assembly — explaining the full allelic spectrum of CDSRR.","evidence":"Patch-clamp electrophysiology of mutant channels in heterologous cells (pore mutations W467G, G478R); yeast two-hybrid showing N-terminal mutations abolish Kv2.1 interaction","pmids":["23115240","21882291"],"confidence":"High","gaps":["Trafficking and surface expression of mutant heteromers not assessed in photoreceptors","Dominant-negative effects of pore-dead heteromers not quantified"]},{"year":2011,"claim":"Beyond retinal disease, KCNV2 variants were shown to modulate epilepsy susceptibility through altered Kv2.1/Kv8.2 channel function in the brain, broadening the physiological relevance of this subunit.","evidence":"Kcnv2 transgene overexpression in Scn2a-Q54 epilepsy mouse model exacerbated seizure severity; nonsynonymous human variants altered heteromeric channel properties","pmids":["21402906"],"confidence":"High","gaps":["Endogenous brain expression pattern and cell-type specificity of Kv8.2 were not defined","Whether Kv8.2 loss alone causes seizures was not tested"]},{"year":2012,"claim":"Discovery that Kcnv2 transcription is circadian-clock-driven and regulated by Crx/Nrl revealed how photoreceptor-specific and temporally patterned expression of this channel subunit is achieved.","evidence":"qPCR and Western blot across circadian time in retina including constant darkness; ChIP identifying Crx/Nrl binding sites; mutagenesis of CBS2 abolishing promoter activity","pmids":["22969075","24664678"],"confidence":"Medium","gaps":["Functional consequence of circadian Kv8.2 fluctuation on photoreceptor physiology was not measured electrophysiologically","Chromatin accessibility changes at the locus were not mapped"]},{"year":2019,"claim":"Kv8.2 knockout mice recapitulated human CDSRR, and comparison with Kv2.1 KO mice dissected the differential contributions of homomeric versus heteromeric channels to ERG a-wave, b-wave, and c-wave components.","evidence":"ERG, OCT, immunohistochemistry, and TUNEL in Kcnv2 KO, Kcnv2/Kcnb1 double KO, and Kcnb1 KO mice","pmids":["30820446"],"confidence":"High","gaps":["Single-cell electrophysiology from KO photoreceptors was not performed","Relative stoichiometry of Kv2.1 homomers versus heteromers in wild-type retina remained unknown"]},{"year":2021,"claim":"Characterization of Kv8.2 KO retinas established that loss of the heteromeric channel causes photoreceptor apoptosis and microglial activation, linking channel dysfunction to cell death rather than purely electrical phenotypes.","evidence":"TUNEL assay, ONL thickness measurement, microglial marker immunostaining in Kv8.2 KO mice","pmids":["34063002"],"confidence":"Medium","gaps":["Whether apoptosis is a direct consequence of altered membrane potential or secondary to calcium dysregulation was unresolved","Time course of degeneration relative to functional loss was not fully defined"]},{"year":2022,"claim":"Identification of Kv8.2/Kv2.1 as components of a macromolecular complex with Na/K-ATPase (ATP1A3) and retinoschisin placed the heteromeric channel within a larger signaling/ionic hub at the photoreceptor inner segment.","evidence":"Reciprocal co-immunoprecipitation from native porcine and murine retinal lysates; immunofluorescence colocalization; retinoschisin-deficient mouse showing complex mislocalization","pmids":["35876901"],"confidence":"High","gaps":["Stoichiometry and structural organization of the complex are unknown","Whether the ATPase–channel interaction is direct or bridged by retinoschisin was not resolved"]},{"year":2025,"claim":"Human retinal organoid models of KCNV2 deficiency revealed upregulation of apoptosis, oxidative stress, and hypoxia pathways, and AAV-mediated gene replacement partially rescued these transcriptional changes, providing preclinical support for gene therapy.","evidence":"CRISPR-edited and patient iPSC-derived retinal organoids; single-cell RNA-seq; AAV-KCNV2 transduction with immunofluorescence quantification of rescued protein interactions","pmids":["41516321"],"confidence":"Medium","gaps":["Functional electrophysiological rescue in organoids was not demonstrated","Long-term stability of AAV-mediated expression was not assessed","Organoid maturation may not fully recapitulate native photoreceptor physiology"]},{"year":null,"claim":"Key unresolved questions include the precise stoichiometry of Kv2.1/Kv8.2 heteromers in native photoreceptors, the structural basis of the heteromeric channel pore, and whether the apoptotic pathway triggered by Kv8.2 loss is driven by calcium overload, metabolic stress, or another mechanism.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or X-ray structure of the Kv2.1/Kv8.2 heteromer exists","Causal pathway from channel loss to photoreceptor death has not been resolved","In vivo gene therapy efficacy in animal models has not been reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,4,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,4]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,10]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,7]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,7]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,4,7]}],"complexes":["Kv2.1/Kv8.2 heteromeric potassium channel","Na/K-ATPase–Kv2.1/Kv8.2–retinoschisin complex"],"partners":["KCNB1","ATP1A3","RS1"],"other_free_text":[]},"mechanistic_narrative":"KCNV2 encodes Kv8.2, an electrically silent voltage-gated potassium channel α-subunit that obligately hetero-tetramerizes with Kv2.1 to form functional channels in photoreceptor inner segments, where it shifts steady-state activation to negative potentials and generates a window current (IKX) that sets the photoreceptor resting membrane potential [PMID:17652418, PMID:16909397]. Kv8.2/Kv2.1 heteromers are part of a macromolecular complex with the Na/K-ATPase (ATP1A3) and retinoschisin at the inner segment membrane, and loss of Kv8.2 leads to photoreceptor apoptosis, outer nuclear layer thinning, and microglial activation [PMID:35876901, PMID:34063002]. Loss-of-function mutations in KCNV2 cause cone dystrophy with supernormal rod electroretinogram response (CDSRR) through two distinct mechanisms: pore-domain mutations yield assembled but non-conducting heteromers, while tetramerization-domain mutations prevent heteromer assembly entirely [PMID:23115240, PMID:16909397]. Retinal Kcnv2 transcription is clock-driven and depends on the photoreceptor transcription factors Crx and Nrl, with a Crx binding site in the promoter essential for expression [PMID:22969075, PMID:24664678]."},"prefetch_data":{"uniprot":{"accession":"Q8TDN2","full_name":"Potassium voltage-gated channel subfamily V member 2","aliases":["Voltage-gated potassium channel subunit Kv8.2"],"length_aa":545,"mass_kda":62.5,"function":"Potassium channel subunit. Modulates channel activity by shifting the threshold and the half-maximal activation to more negative values","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q8TDN2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNV2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNV2","total_profiled":1310},"omim":[{"mim_id":"610438","title":"RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3","url":"https://www.omim.org/entry/610438"},{"mim_id":"610356","title":"CONE DYSTROPHY WITH SUPERNORMAL ROD RESPONSES; CDSRR","url":"https://www.omim.org/entry/610356"},{"mim_id":"607604","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY V, MEMBER 2; KCNV2","url":"https://www.omim.org/entry/607604"},{"mim_id":"600397","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAB-RELATED SUBFAMILY, MEMBER 1; KCNB1","url":"https://www.omim.org/entry/600397"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":268.2}],"url":"https://www.proteinatlas.org/search/KCNV2"},"hgnc":{"alias_symbol":["Kv8.2"],"prev_symbol":[]},"alphafold":{"accession":"Q8TDN2","domains":[{"cath_id":"3.30.710.10","chopping":"97-216","consensus_level":"high","plddt":91.7984,"start":97,"end":216},{"cath_id":"1.20.120.350","chopping":"230-288_299-358_380-394","consensus_level":"high","plddt":83.9236,"start":230,"end":394},{"cath_id":"1.10.287.70","chopping":"401-514","consensus_level":"high","plddt":91.0826,"start":401,"end":514}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDN2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDN2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDN2-F1-predicted_aligned_error_v6.png","plddt_mean":75.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNV2","jax_strain_url":"https://www.jax.org/strain/search?query=KCNV2"},"sequence":{"accession":"Q8TDN2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TDN2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TDN2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDN2"}},"corpus_meta":[{"pmid":"16909397","id":"PMC_16909397","title":"Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause \"cone dystrophy with supernormal rod electroretinogram\" in humans.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16909397","citation_count":106,"is_preprint":false},{"pmid":"18235024","id":"PMC_18235024","title":"Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18235024","citation_count":76,"is_preprint":false},{"pmid":"21402906","id":"PMC_21402906","title":"Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21402906","citation_count":71,"is_preprint":false},{"pmid":"17652418","id":"PMC_17652418","title":"Characterization of the heteromeric potassium channel formed by kv2.1 and the retinal subunit kv8.2 in Xenopus oocytes.","date":"2007","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/17652418","citation_count":65,"is_preprint":false},{"pmid":"21558291","id":"PMC_21558291","title":"High-resolution optical coherence tomography imaging in KCNV2 retinopathy.","date":"2011","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/21558291","citation_count":51,"is_preprint":false},{"pmid":"21882291","id":"PMC_21882291","title":"Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21882291","citation_count":42,"is_preprint":false},{"pmid":"23221069","id":"PMC_23221069","title":"Phenotypic characteristics including in vivo cone photoreceptor mosaic in KCNV2-related \"cone dystrophy with supernormal rod electroretinogram\".","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23221069","citation_count":42,"is_preprint":false},{"pmid":"17896311","id":"PMC_17896311","title":"Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram.","date":"2007","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17896311","citation_count":40,"is_preprint":false},{"pmid":"18400204","id":"PMC_18400204","title":"Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.","date":"2008","source":"American journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/18400204","citation_count":35,"is_preprint":false},{"pmid":"23077521","id":"PMC_23077521","title":"Rod and cone function in patients with KCNV2 retinopathy.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23077521","citation_count":27,"is_preprint":false},{"pmid":"32441199","id":"PMC_32441199","title":"KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy.","date":"2020","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32441199","citation_count":26,"is_preprint":false},{"pmid":"30820446","id":"PMC_30820446","title":"The Role of the Voltage-Gated Potassium Channel Proteins Kv8.2 and Kv2.1 in Vision and Retinal Disease: Insights from the Study of Mouse Gene Knock-Out Mutations.","date":"2019","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/30820446","citation_count":25,"is_preprint":false},{"pmid":"23725738","id":"PMC_23725738","title":"Cone dystrophy with supernormal rod response: novel KCNV2 mutations in an underdiagnosed phenotype.","date":"2013","source":"Ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/23725738","citation_count":22,"is_preprint":false},{"pmid":"22969075","id":"PMC_22969075","title":"The retinal clock drives the expression of Kcnv2, a channel essential for visual function and cone survival.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22969075","citation_count":19,"is_preprint":false},{"pmid":"23115240","id":"PMC_23115240","title":"Functional analysis of missense mutations in Kv8.2 causing cone dystrophy with supernormal rod electroretinogram.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23115240","citation_count":17,"is_preprint":false},{"pmid":"23885164","id":"PMC_23885164","title":"Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants.","date":"2013","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/23885164","citation_count":16,"is_preprint":false},{"pmid":"21911584","id":"PMC_21911584","title":"Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p.G461R mutation of KCNV2.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21911584","citation_count":15,"is_preprint":false},{"pmid":"34063002","id":"PMC_34063002","title":"Molecular, Cellular and Functional Changes in the Retinas of Young Adult Mice Lacking the Voltage-Gated K+ Channel Subunits Kv8.2 and K2.1.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34063002","citation_count":15,"is_preprint":false},{"pmid":"30927187","id":"PMC_30927187","title":"Two-color pupillometry in KCNV2 retinopathy.","date":"2019","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/30927187","citation_count":9,"is_preprint":false},{"pmid":"35876901","id":"PMC_35876901","title":"Retinoschisin and novel Na/K-ATPase interaction partners Kv2.1 and Kv8.2 define a growing protein complex at the inner segments of mammalian photoreceptors.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35876901","citation_count":9,"is_preprint":false},{"pmid":"24664678","id":"PMC_24664678","title":"RETINA-specific expression of Kcnv2 is controlled by cone-rod homeobox (Crx) and neural retina leucine zipper (Nrl).","date":"2014","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/24664678","citation_count":5,"is_preprint":false},{"pmid":"34535971","id":"PMC_34535971","title":"Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family.","date":"2021","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34535971","citation_count":5,"is_preprint":false},{"pmid":"29210963","id":"PMC_29210963","title":"CENTRAL ELLIPSOID LOSS ASSOCIATED WITH CONE DYSTROPHY AND KCNV2 MUTATION.","date":"2018","source":"Retinal cases & brief reports","url":"https://pubmed.ncbi.nlm.nih.gov/29210963","citation_count":5,"is_preprint":false},{"pmid":"37852740","id":"PMC_37852740","title":"KCNV2-associated retinopathy: genotype-phenotype correlations - KCNV2 study group report 3.","date":"2024","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/37852740","citation_count":4,"is_preprint":false},{"pmid":"33706576","id":"PMC_33706576","title":"Cone dystrophy with supernormal rod responses: A rare KCNV2 gene variant.","date":"2021","source":"European journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/33706576","citation_count":4,"is_preprint":false},{"pmid":"23143909","id":"PMC_23143909","title":"Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.","date":"2012","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/23143909","citation_count":4,"is_preprint":false},{"pmid":"37121194","id":"PMC_37121194","title":"Generation of two human induced pluripotent stem cell lines (ABi001-A and ABi002-A) from cone dystrophy with supernormal rod response patients caused by KCNV2 mutation.","date":"2023","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/37121194","citation_count":3,"is_preprint":false},{"pmid":"39792073","id":"PMC_39792073","title":"Retinal Sensitivity in KCNV2-Associated Retinopathy.","date":"2025","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/39792073","citation_count":2,"is_preprint":false},{"pmid":"41516321","id":"PMC_41516321","title":"KCNV2-Deficient Retinal Organoid Model of Cone Dystrophy-In Vitro Screening for AAV Gene Replacement Therapy.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41516321","citation_count":1,"is_preprint":false},{"pmid":"38454848","id":"PMC_38454848","title":"Structural and functional characterization of an individual with the M285R KCNV2 hypomorphic allele.","date":"2024","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38454848","citation_count":1,"is_preprint":false},{"pmid":"32154435","id":"PMC_32154435","title":"Pseudodominance in two families with KCNV2 related retinopathy.","date":"2020","source":"American journal of ophthalmology case reports","url":"https://pubmed.ncbi.nlm.nih.gov/32154435","citation_count":1,"is_preprint":false},{"pmid":"33960280","id":"PMC_33960280","title":"A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.","date":"2021","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33960280","citation_count":1,"is_preprint":false},{"pmid":"39200733","id":"PMC_39200733","title":"Novel and Previously Known Mutations of the KCNV2 Gene Cause Various Variants of the Clinical Course of Cone Dystrophy with Supernormal Rod Response in Children.","date":"2024","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39200733","citation_count":0,"is_preprint":false},{"pmid":"38630375","id":"PMC_38630375","title":"Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy.","date":"2024","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/38630375","citation_count":0,"is_preprint":false},{"pmid":"39083856","id":"PMC_39083856","title":"Establishment of a human induced pluripotent stem cell line (ABi004-A) carrying a compound heterozygous mutation in the KCNV2 gene.","date":"2024","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39083856","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19299,"output_tokens":3213,"usd":0.053046},"stage2":{"model":"claude-opus-4-6","input_tokens":6566,"output_tokens":2768,"usd":0.153045},"total_usd":0.206091,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"KCNV2 is expressed in human rod and cone photoreceptors (demonstrated by in situ hybridization), and loss-of-function mutations cause cone dystrophy with supernormal rod ERG, suggesting KCNV2 encodes a subunit that perturbs or abrogates IKX, the potassium current within vertebrate photoreceptor inner segments that sets their resting potential and voltage response.\",\n      \"method\": \"In situ hybridization; homozygosity mapping; Sanger sequencing of disease-linked mutations\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational discovery paper with >100 citations, direct localization experiment plus genetic linkage to channel function\",\n      \"pmids\": [\"16909397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Kv8.2 (KCNV2) cannot form homotetrameric channels on its own but co-assembles with Kv2.1 to form functional heteromeric channels. In Xenopus oocytes, Kv8.2 shifts Kv2.1 steady-state activation to more negative potentials, generating a window current in the −40 to −10 mV range, and produces transient hyperpolarizing overshoots resembling photoreceptor responses to light. The disease-causing mutation G476D abolishes functional heteromer formation.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes; two-electrode voltage clamp; current-clamp experiments; site-directed mutagenesis\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted heteromeric channel in oocytes with mutagenesis validation, >60 citations\",\n      \"pmids\": [\"17652418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KCNV2 (Kv8.2) contributes to epilepsy susceptibility by modulating Kv2.1/Kv8.2 heterotetrameric potassium channel function; nonsynonymous human KCNV2 variants identified in epilepsy patients alter Kv2.1/Kv8.2 channel function, and Kcnv2 transgene overexpression exacerbates seizure severity in a mouse model (Scn2a Q54).\",\n      \"method\": \"Transgenic mouse in vivo epilepsy model; electrophysiology of heteromeric channels; identification of nonsynonymous variants with functional assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo exacerbation by transgene plus functional channel assay, >70 citations\",\n      \"pmids\": [\"21402906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"N-terminal missense mutations in Kv8.2 (KCNV2) dramatically reduce or abolish interaction with Kv2.1, as shown by yeast two-hybrid assay, indicating that failure of heteromeric Kv channel assembly is one underlying pathomechanism of cone dystrophy with supernormal rod response.\",\n      \"method\": \"Yeast two-hybrid interaction assay with disease-associated KCNV2 N-terminal missense mutations\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single method (yeast two-hybrid), but consistent with oocyte functional data from other labs\",\n      \"pmids\": [\"21882291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Two distinct molecular mechanisms underlie KCNV2-associated disease: pore-domain missense mutations (W467G, G478R) allow Kv2.1/Kv8.2 heteromer assembly but render channels non-conducting, whereas tetramerization-domain missense mutations prevent heteromer formation and result in homomeric Kv2.1 channels only.\",\n      \"method\": \"Heterologous expression of mutant channels; patch-clamp electrophysiology; site-directed mutagenesis in tetramerization and pore domains\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional reconstitution with domain-specific mutagenesis distinguishing two mechanisms\",\n      \"pmids\": [\"23115240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Transcription of Kcnv2 (and Kv2.1) in the retina follows a circadian rhythm driven by the endogenous retinal clock, with peak mRNA and Kv8.2 protein levels at night; this rhythm persists under constant darkness, indicating clock-controlled transcriptional regulation of potassium channel subunit expression in photoreceptors.\",\n      \"method\": \"Quantitative PCR of whole retina and microdissected photoreceptors across time; Western blot; constant-darkness experiments\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (qPCR + Western blot + constant darkness), single lab\",\n      \"pmids\": [\"22969075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Retina-specific expression of Kcnv2 is controlled by the transcription factors Crx and Nrl; ChIP identified two Crx binding sites (CBS) and one Nrl binding site in the Kcnv2 promoter, with CBS2 shown to be essential by site-directed mutagenesis. In vivo electroporation showed that Kv8.2 protein localizes to the inner segment membranes of photoreceptors.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); reporter electroporation of retinal explants; shRNA knockdown of Crx/Nrl; site-directed mutagenesis of promoter; qRT-PCR; in vivo electroporation for subcellular localization\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, mutagenesis, reporter assay, localization), single lab\",\n      \"pmids\": [\"24664678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Kv8.2 (Kcnv2) knockout mice recapitulate key features of human CDSRR including a depressed a-wave and elevated b-wave with bright light stimulation; Kv2.1 KO mice show depressed a-wave but lack the elevated b-wave, indicating that homomeric Kv2.1 channels and heteromeric Kv2.1/Kv8.2 channels differentially contribute to ERG components. In all three KO genotypes (Kv8.2 KO, Kv2.1 KO, double KO), the c-wave is totally absent, linking the Kv2.1/Kv8.2 heteromeric channel to c-wave generation.\",\n      \"method\": \"Genetic knockout mouse models; electroretinography (ERG); OCT imaging; immunohistochemistry; TUNEL assay\",\n      \"journal\": \"eNeuro\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined ERG phenotype, reciprocal KO comparison clarifying channel composition requirement, multiple orthogonal readouts\",\n      \"pmids\": [\"30820446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of Kv8.2 (Kv8.2 KO mouse) causes early retinal pathology including significantly higher apoptotic cells, thinning of the outer nuclear layer, and increased activated microglia in the subretinal space, establishing that Kv8.2 is required for photoreceptor survival and normal retinal immune homeostasis.\",\n      \"method\": \"Kv8.2 and Kv2.1 knockout mouse models; TUNEL assay; OCT; immunohistochemistry for microglial markers; ERG\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal cellular phenotype readouts, single lab\",\n      \"pmids\": [\"34063002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disease-causing KCNV2 mutations cause either failure of Kv8.2 protein expression or failure of Kv8.2 to interact with Kv2.1, as demonstrated by immunoblotting and co-immunoprecipitation in vitro.\",\n      \"method\": \"Co-immunoprecipitation; immunoblotting; qRT-PCR in transfected cells\",\n      \"journal\": \"Molecular genetics & genomic medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method (Co-IP/Western), but corroborates established mechanism from multiple prior studies\",\n      \"pmids\": [\"34535971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kv2.1 and Kv8.2 are direct interaction partners of the retinal Na/K-ATPase (ATP1A3 subunit) at the photoreceptor inner segment membrane, forming a macromolecular complex that also includes retinoschisin. Retinoschisin deficiency causes mislocalization of this complex and concurrent reduction of Kv2.1 and Kv8.2 protein levels without affecting Na/K-ATPase expression.\",\n      \"method\": \"Co-immunoprecipitation with porcine and murine retinal lysates; colocalization by immunofluorescence; patch-clamp analysis; retinoschisin-deficient mouse model\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP from native retinal tissue plus KO model showing functional complex mislocalization, multiple orthogonal methods\",\n      \"pmids\": [\"35876901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"KCNV2-deficient photoreceptors (in human retinal organoids) show upregulation of genes associated with apoptosis, oxidative stress, and hypoxia pathways; AAV-mediated KCNV2 replacement partially restores these transcriptional changes and rescues Kv8.2 protein expression and its interactions with potassium channel binding partners.\",\n      \"method\": \"KCNV2-deficient retinal organoids (iPSC-derived and CRISPR gene-edited); AAV transduction; single-cell RNA sequencing; immunofluorescence quantification of protein interactions\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — organoid loss-of-function with single-cell RNAseq and rescue by gene replacement, single lab\",\n      \"pmids\": [\"41516321\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNV2 encodes Kv8.2, an electrically silent voltage-gated potassium channel α-subunit that cannot form homotetrameric channels alone but obligately co-assembles with Kv2.1 into heteromeric channels at photoreceptor inner segment membranes; within this heteromer, Kv8.2 shifts activation to more negative potentials and generates a window current (IKX) that sets the photoreceptor resting potential, while also forming part of a larger macromolecular complex with the retinal Na/K-ATPase and retinoschisin. Disease mutations cause either non-conducting heteromers (pore-domain mutations) or failure of heteromer assembly (tetramerization-domain mutations), leading to photoreceptor apoptosis and cone dystrophy with supernormal rod response. Kcnv2 transcription is clock-driven and regulated by the retinal transcription factors Crx and Nrl.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNV2 encodes Kv8.2, an electrically silent voltage-gated potassium channel α-subunit that obligately hetero-tetramerizes with Kv2.1 to form functional channels in photoreceptor inner segments, where it shifts steady-state activation to negative potentials and generates a window current (IKX) that sets the photoreceptor resting membrane potential [PMID:17652418, PMID:16909397]. Kv8.2/Kv2.1 heteromers are part of a macromolecular complex with the Na/K-ATPase (ATP1A3) and retinoschisin at the inner segment membrane, and loss of Kv8.2 leads to photoreceptor apoptosis, outer nuclear layer thinning, and microglial activation [PMID:35876901, PMID:34063002]. Loss-of-function mutations in KCNV2 cause cone dystrophy with supernormal rod electroretinogram response (CDSRR) through two distinct mechanisms: pore-domain mutations yield assembled but non-conducting heteromers, while tetramerization-domain mutations prevent heteromer assembly entirely [PMID:23115240, PMID:16909397]. Retinal Kcnv2 transcription is clock-driven and depends on the photoreceptor transcription factors Crx and Nrl, with a Crx binding site in the promoter essential for expression [PMID:22969075, PMID:24664678].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying KCNV2 as the gene mutated in cone dystrophy with supernormal rod ERG established that an electrically silent Kv subunit expressed in photoreceptors is essential for normal visual function.\",\n      \"evidence\": \"Homozygosity mapping, Sanger sequencing of affected families, and in situ hybridization localizing KCNV2 mRNA to rod and cone photoreceptors\",\n      \"pmids\": [\"16909397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional mechanism of Kv8.2 in photoreceptor physiology was unknown\", \"Whether Kv8.2 formed channels alone or required a partner was untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Reconstitution of Kv8.2/Kv2.1 heteromeric channels demonstrated that Kv8.2 cannot conduct alone but shifts Kv2.1 activation negatively, producing a window current resembling the photoreceptor IKX.\",\n      \"evidence\": \"Two-electrode voltage clamp of Kv8.2 ± Kv2.1 in Xenopus oocytes; current-clamp showing hyperpolarizing overshoots; G476D mutagenesis abolishing function\",\n      \"pmids\": [\"17652418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo confirmation in photoreceptors was lacking\", \"Other potential heteromeric partners not excluded\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Distinguishing pore-domain from tetramerization-domain mutations revealed two separable pathomechanisms — non-conducting assembled heteromers versus failure of assembly — explaining the full allelic spectrum of CDSRR.\",\n      \"evidence\": \"Patch-clamp electrophysiology of mutant channels in heterologous cells (pore mutations W467G, G478R); yeast two-hybrid showing N-terminal mutations abolish Kv2.1 interaction\",\n      \"pmids\": [\"23115240\", \"21882291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking and surface expression of mutant heteromers not assessed in photoreceptors\", \"Dominant-negative effects of pore-dead heteromers not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Beyond retinal disease, KCNV2 variants were shown to modulate epilepsy susceptibility through altered Kv2.1/Kv8.2 channel function in the brain, broadening the physiological relevance of this subunit.\",\n      \"evidence\": \"Kcnv2 transgene overexpression in Scn2a-Q54 epilepsy mouse model exacerbated seizure severity; nonsynonymous human variants altered heteromeric channel properties\",\n      \"pmids\": [\"21402906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous brain expression pattern and cell-type specificity of Kv8.2 were not defined\", \"Whether Kv8.2 loss alone causes seizures was not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that Kcnv2 transcription is circadian-clock-driven and regulated by Crx/Nrl revealed how photoreceptor-specific and temporally patterned expression of this channel subunit is achieved.\",\n      \"evidence\": \"qPCR and Western blot across circadian time in retina including constant darkness; ChIP identifying Crx/Nrl binding sites; mutagenesis of CBS2 abolishing promoter activity\",\n      \"pmids\": [\"22969075\", \"24664678\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of circadian Kv8.2 fluctuation on photoreceptor physiology was not measured electrophysiologically\", \"Chromatin accessibility changes at the locus were not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Kv8.2 knockout mice recapitulated human CDSRR, and comparison with Kv2.1 KO mice dissected the differential contributions of homomeric versus heteromeric channels to ERG a-wave, b-wave, and c-wave components.\",\n      \"evidence\": \"ERG, OCT, immunohistochemistry, and TUNEL in Kcnv2 KO, Kcnv2/Kcnb1 double KO, and Kcnb1 KO mice\",\n      \"pmids\": [\"30820446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-cell electrophysiology from KO photoreceptors was not performed\", \"Relative stoichiometry of Kv2.1 homomers versus heteromers in wild-type retina remained unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Characterization of Kv8.2 KO retinas established that loss of the heteromeric channel causes photoreceptor apoptosis and microglial activation, linking channel dysfunction to cell death rather than purely electrical phenotypes.\",\n      \"evidence\": \"TUNEL assay, ONL thickness measurement, microglial marker immunostaining in Kv8.2 KO mice\",\n      \"pmids\": [\"34063002\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether apoptosis is a direct consequence of altered membrane potential or secondary to calcium dysregulation was unresolved\", \"Time course of degeneration relative to functional loss was not fully defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of Kv8.2/Kv2.1 as components of a macromolecular complex with Na/K-ATPase (ATP1A3) and retinoschisin placed the heteromeric channel within a larger signaling/ionic hub at the photoreceptor inner segment.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation from native porcine and murine retinal lysates; immunofluorescence colocalization; retinoschisin-deficient mouse showing complex mislocalization\",\n      \"pmids\": [\"35876901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural organization of the complex are unknown\", \"Whether the ATPase–channel interaction is direct or bridged by retinoschisin was not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Human retinal organoid models of KCNV2 deficiency revealed upregulation of apoptosis, oxidative stress, and hypoxia pathways, and AAV-mediated gene replacement partially rescued these transcriptional changes, providing preclinical support for gene therapy.\",\n      \"evidence\": \"CRISPR-edited and patient iPSC-derived retinal organoids; single-cell RNA-seq; AAV-KCNV2 transduction with immunofluorescence quantification of rescued protein interactions\",\n      \"pmids\": [\"41516321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional electrophysiological rescue in organoids was not demonstrated\", \"Long-term stability of AAV-mediated expression was not assessed\", \"Organoid maturation may not fully recapitulate native photoreceptor physiology\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the precise stoichiometry of Kv2.1/Kv8.2 heteromers in native photoreceptors, the structural basis of the heteromeric channel pore, and whether the apoptotic pathway triggered by Kv8.2 loss is driven by calcium overload, metabolic stress, or another mechanism.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or X-ray structure of the Kv2.1/Kv8.2 heteromer exists\", \"Causal pathway from channel loss to photoreceptor death has not been resolved\", \"In vivo gene therapy efficacy in animal models has not been reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 4, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 4, 7]}\n    ],\n    \"complexes\": [\n      \"Kv2.1/Kv8.2 heteromeric potassium channel\",\n      \"Na/K-ATPase–Kv2.1/Kv8.2–retinoschisin complex\"\n    ],\n    \"partners\": [\n      \"KCNB1\",\n      \"ATP1A3\",\n      \"RS1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}